Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Advances in DNA Vaccines
| Advances in DNA Vaccines |
| Autore | Isaguliants Maria |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (210 p.) |
| Soggetto topico |
Epidemiology and Medical statistics
Medicine and Nursing |
| Soggetto non controllato |
adjuvant
adjuvants AIDS alphaviruses antibodies artificial T-cell antigens BCG bicistronic circovirus clinical trial computer design cytolytic Cytolytic T Lymphocytes DNA DNA immunization DNA vaccine DNA vaccine constructs DNA vaccines EBNA1 ebola virus disease enhancer element Epstein-Barr virus flagellin formulations gene expression HCV HCV vaccine hepatitis C virus (HCV) HIV HIV-1 HTI IL-36 immune response immune responses immunization immunogenicity in vitro transcribed mRNA influenza innate immunity intranasal latent proteins layered RNA/DNA vectors lipid LMP1 LMP2 mesenchymal stem cells (MSC) modified MSC mRNA vaccine myeloid derived suppressor cells (MDSCs) n/a nonstructural HCV proteins perforin plasmid plasmid DNA protection against tumor challenges and infectious agents rBCG recombinant particles RNA replicons T-cell therapeutic vaccine tumor regression vaccine vaccine delivery Zika |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557354503321 |
Isaguliants Maria
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Chronic HCV Infection: Clinical Advances and Eradication Perspectives
| Chronic HCV Infection: Clinical Advances and Eradication Perspectives |
| Autore | Liberto Maria Carla |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (104 p.) |
| Soggetto topico |
Epidemiology and Medical statistics
Medicine and Nursing |
| Soggetto non controllato |
children
chronic hepatitis C COVID-19 direct-acting antivirals elimination fibrosis genotype 3 HCV HCV eradication hepatitis C hepatitis C virus (HCV) hepatocellular carcinoma homeless persons interferon ledipasvir/sofosbuvir liver cirrhosis model mortality n/a out-of-hospital pangenotypic phylogeny PWID real-life resistance-associated substitution (RAS) retention in care rheumatic steatosis sustained virological response vibration controlled transient elastography |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Chronic HCV Infection |
| Record Nr. | UNINA-9910557608603321 |
|
Liberto Maria Carla
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Targeting STAT3 and STAT5 in Cancer
| Targeting STAT3 and STAT5 in Cancer |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (578 p.) |
| Soggetto topico |
Biology, life sciences
Research & information: general |
| Soggetto non controllato |
ADAM17
adoptive T cell therapy AKT androgens apoptosis autoimmune disease autosomal-dominant hyper IgE syndrome Bone Marrow Failure Syndromes breast cancer cancer cancer models cancer progression cancer-stem cell CD38 CD4+ T cells CD8+ T cells cell cycle cell hierarchy chaperones chemotherapy resistance cirrhosis colon cancer companion animals comparative oncology cytokine cytokine receptor signaling dynamic programming endoplasmic reticulum (ER) stress epidermal growth factor receptor (EGF-R) ERK1/2 escape mechanisms gain-of-function mutation glioblastoma glioma growth hormone insensitivity syndrome heat shock proteins hedging hematopoietic cancers hepatitis C virus (HCV) hepatocellular carcinoma (HCC) hepatocyte nuclear factor 4 alpha (HNF4A) immune check point immune suppression immunosuppression immunotherapy inflammation inflammation associated cancer inflammatory hepatocellular adenomas interleukin-6 JAK JAK family of protein tyrosine kinases JAK2 V617F knockout lipopolyplex lung cancer lymphocytes lymphoma M2 macrophages melanoma meta-analysis metalloprotease metastasis microRNA-122 (miR-122) mitochondria MPN mTOR multiple myeloma mutations myeloid cells myeloid leukemia n/a nanoparticle neoplastic stem cells NGS NK cells nuclear factor erythroid 2-related factor 2 (NRF2) nuclear pore complex nuclear transport receptors nucleocytoplasmic shuttling ovarian cancer oxidative stress (OS) PD-L1 PEI pharmacological inhibitor pharmacological inhibitors polyethylenimine post-decision state variable prolactin proliferation prostate cancer RHOA risk management S3I-1757 SH2 domain shedding signal transducer and activator of transcription signal transducer and activator of transcription 3 (STAT3) siRNA delivery siRNA/RNAi small-molecule inhibitors solid cancers stabilization STAT STAT transcription factors STAT3 STAT3 inhibitor XIII STAT5 STAT5 signaling STAT5B signaling stem/progenitor cells stemness T-cell large granular lymphocytic leukemia T-cell leukemia T-cell prolymphocytic leukemia T-cells T-PLL targeted therapy targeting therapeutic targeting therapy resistance trans-signaling transaction costs tumor microenvironment tumor necrosis factor alpha (TNFα) tumor suppression tumor-associated macrophages tumor-immune cell interactions tumorigenesis tyrosine kinase 2 unfolded protein response (UPR) |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557623503321 |
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||